SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001213900-19-015961
Filing Date
2019-08-15
Accepted
2019-08-15 08:45:58
Documents
3
Effectiveness Date
2019-08-15

Document Format Files

Seq Description Document Type Size
1 FORM POS EX posex2019a1_delmarpharma.htm POS EX 33070
2 LEGAL OPINION OF FENNEMORE CRAIG, P.C. posex2019a1ex5-1_delmar.htm EX-5.1 29806
3 LEGAL OPINION OF LOWENSTEIN SANDLER LLP posex2019a1ex5-2_delmar.htm EX-5.2 13739
  Complete submission text file 0001213900-19-015961.txt   77707
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: POS EX | Act: 33 | File No.: 333-232931 | Film No.: 191028575
SIC: 2834 Pharmaceutical Preparations